Brazilian Journal of Pain
https://brjp.org.br/article/doi/10.5935/2595-0118.20180065
Brazilian Journal of Pain
Original Article

The prevalence of fibromyalgia in Brazil – a population-based study with secondary data of the study on chronic pain prevalence in Brazil

A prevalência da fibromialgia no Brasil – estudo de base populacional com dados secundários da pesquisa de prevalência de dor crônica brasileira

Juliana Barcellos de Souza; Dirce Maria Navas Perissinotti

http://dx.doi.org/10.5935/2595-0118.20180065 BrJP, vol.1, n4, p.345-348, 2018
PDF English
PDF Português
SciELO
Downloads: 1
Views: 1365

Abstract

BACKGROUND AND OBJECTIVES: The prevalence of the fibromyalgia syndrome has been estimated in some Brazilian cities and regions, and previous population-based studies investigating this prevalence, as well as the profile of medical consultations are unknown.

METHODS: This study used the database constructed by a previous study of authors to identify the prevalence of chronic pain in Brazil. The cases that reported pain for more than 6 months and with a diagnosis of fibromyalgia were selected. The studied descriptive variables were age, intensity and frequency of pain, pain interference in self-care, walking, working, social life, sexual life, sleep quality, if pain causes sadness or depression or influences the emotional aspects. The total sample was evaluated by rheumatologists and pain-expert doctors.

RESULTS: Thirteen cases from the initial database were selected since they reported the diagnosis of the prevalence of the fibromyalgia syndrome representing 2% of the initial study population, average age 35.8 years (9.8). The predominance of the fibromyalgia syndrome was in females (n=11). Pain intensity was 7.3 (2.4), the frequency and duration of pain were constant in the majority of the sample (n=9). Most of the cases report a serious pain interference with sleep (n=8), many said that pain interferes with the work (n=5), irritability (5) and finally, some report that pain has a moderate interference in self-care (n=5), walking (n=6), social life (n=6), sexual life (n=5) and causes moderate sadness or depression (n=5).

CONCLUSION: The prevalence of the fibromyalgia syndrome was estimated in 2% of the Brazilian population, based on secondary data of a study on chronic pain prevalence in Brazil. The data was collected in 2015-2016. The most reported complaints were intense and daily pain that interferes with sleep.

Keywords

Constant pain, Fibromyalgia syndrome, Intense pain, Prevalence, Sleep

Resumo

JUSTIFICATIVA E OBJETIVOS: A prevalência de síndrome de fibromialgia já foi estimada em cidades e regiões pontuais do Brasil, desconhece-se estudos anteriores de base populacional que investiguem a prevalência, assim como o perfil de consultas médicas.

MÉTODOS: Este estudo utilizou dados secundários ao banco de dados construído por uma pesquisa prévia para identificar a prevalência de dor crônica no Brasil. Foram selecionados os casos que responderam sentir dores há mais de 6 meses e com diagnóstico de fibromialgia. As variáveis analisadas de forma descritiva foram: idade, intensidade e frequência da dor, interferência da dor no autocuidado, na caminhada, no trabalho, na vida social, na vida sexual, na qualidade do sono, se dor causa tristeza ou deprime ou influencia os aspectos emocionais. A totalidade da amostra foi avaliada tanto por reumatologistas como por especialistas em dor.

RESULTADOS: Treze casos do banco de dados inicial foram selecionados por afirmarem ter recebido o diagnóstico de síndrome de fibromialgia, representando 2% da população do estudo inicial, idade média de 35,8 anos (9,8). A predominância de síndrome de fibromialgia foi no gênero feminino (n=11). Intensidade de dor de 7,3 (2,4), a frequência e duração da dor é constante na maioria da amostra (n=9). A maioria dos casos relata muita interferência da dor no sono (n=8), alguns classificam que a dor interfere muito no trabalho (n=5), irritabilidade (5) e finalmente, alguns relatam que a dor interfere moderadamente no autocuidado (n=5), caminhada (n=6), vida social (n=6), vida sexual (n=5) e causa moderamente tristeza ou deprime (n=5).

CONCLUSÃO: A prevalência da síndrome de fibromialgia foi estimada em 2% da população brasileira pelo viés de dados secundários de um estudo de prevalência de dor crônica no Brasil cujo dados foram coletados em 2015-2016. As queixas relatadas pela maioria dos casos foram de dor intensa e diária e com interferência da dor no sono.

Palavras-chave

Dor constante, Dor intensa, Prevalência, Síndrome de fibromialgia, Sono

References

Marques AP, Santo AS, Berssaneti AA, Matsutani LA, Yuan SL. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol. 2017;57(4):356-63.

Avila LA, de Araujo Filho GM, Guimarães EF, Gonçalves LC, Paschoalin PN, Aleixo FB. Characterization of the pain, Sleep and alexithymia patterns of patients with fibromyalgia treated in a Brazilian tertiary center. Rev Bras Reumatol. 2014;54(5):409-13.

The Global Burden of Disease: Generating Evidence, Guiding Policy.. 2013.

Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004;31(3):594-7.

Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26-35.

Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39(6):448-53.

White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada. J Rheumatol. 1999;26(4):885-9.

Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61(9):1498-508.

Albuquerque MV, Viana AL, Lima LD, Ferreira MP, Fusaro ER, Iozzi FL. Desigualdades regionais na saúde: mudanças observadas no Brasil de 2000 a 2016. Ciênc Saúde Coletiva. 2017;22(4):1055-64.

de Souza JB, Grossmann E, Perissinotti DMN, de Oliveira Junior JO, da Fonseca PRB, Posso IP. Prevalence of chronic pain, treatments, perception, and interference on life activities: Brazilian population-based survey. Pain Res Manag. 2017;2017:4643830.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600-10.

Heymann RE, Paiva ES, Martinez JE, Helfenstein Jr M, Rezende MC, Provenza JR. New guidelines for the diagnosis of fibromyalgia. Rev Bras Reumatol. 2017;57(^sSuppl 1):S467-76.

Poluha RP, Grossmann E. Does pregabalin improve sleep disorders in fibromyalgia. Br J Pain. 2018;1(2):163-6.

Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(3):160-72.

Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113-22.

Charest J, Boucher J, Duhaime S, Nguyen D-N, Chaize E, Barcellos de Souza J. Prescription de tâches personnalisées en intervention stratégique pour la douleur chronique. Revue québécoise de psychologie,. 2015;36:233-50.

Souza JB, Bourgault P, Charest J, Marchand S. Programa de promoção da saúde em pacientes com fibromialgia - avaliação qualitativa e quantitativa. Revista Dor (São Paulo). 2009;10:98-105.

Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-28.

Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M. The National Fibromyalgia Guideline Advisory Panel 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: Executive summary. Pain Res Manag,. 2013;18(3):119-26.

Moldofsky H. The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome. CNS Spectr. 2008;13(3^sSuppl 5):22-6.

Latorre P, Santos M, Heredia-Jiménez J, Delgado-Fernández M, Soto V, Mañas A. Effect of a 24-week physical training programme (in water and on land) on pain, functional capacity, body composition and quality of life in women with fibromyalgia. Clin Exp Rheumatol. 2013;31(6^sSuppl 79):S72-80.

International Classification of functioning, disability and health: ICF. 2001.

Russell D, Álvarez Gallardo IC, Wilson I, Hughes CM, Davison GW, Sañudo B. 'Exercise to me is a scary word': perceptions of fatigue, sleep dysfunction, and exercise in people with fibromyalgia syndrome-a focus group study. Rheumatol Int. 2018;38(3):507-15.

Farin E, Ullrich A, Hauer J. Participation and social functioning in patients with fibromyalgia: development and testing of a new questionnaire. Health Qual Life Outcomes. 2013;11:135.

Orellana C, Casado E, Masip M, Galisteo C, Gratacós J, Larrosa M. Sexual dysfunction in fibromyalgia patients. Clin Exp Rheumatol. 2008;26(4):663-6.

Rosenbaum TY. Musculoskeletal pain and sexual function in women. J Sex Med. 2010;7(2):645-53.

Collado-Mateo D, Olivares PR, Adsuar JC, Gusi N. Impact of fibromyalgia on sexual function in women. J Back Musculoskelet Rehabil. 2018.

Yuan SLK, Marques AP. Development of ProFibro - a mobile application to promote self-care in patients with fibromyalgia. Physiotherapy. 2018;104(3):311-7.

Submitted date:
08/31/2018

Accepted date:
09/24/2018

5f1f89fc0e88252518dc677b brjp Articles
2595-3192 (Electronic) 2595-0118 (Printed)
BrJP ©2024 All rights reserved.

BrJP

Share this page
Page Sections